Business context and reporting period
The supplied filing is Silver Spike Investment Corp.’s unaudited Form 10-Q for the quarter ended March 31, 2024, not a filing under the name Chicago Atlantic BDC, Inc. The company expected to be renamed Chicago Atlantic BDC, Inc. following specified transaction steps. It is an externally managed business development company (BDC) focused at the time on lending to cannabis-related businesses; an expanded strategy allowing investments outside cannabis and health and wellness took effect April 22, 2024.
Financial and portfolio highlights
| Metric | Q1 2024 / March 31, 2024 | Comparable period / prior year-end |
|---|---|---|
| Investment income | $2.76 million | $2.46 million in Q1 2023 |
| Total expenses | $2.84 million | $1.09 million in Q1 2023 |
| Net investment income (loss) | $(79,809); $(0.01) per share | $1.37 million; $0.22 per share in Q1 2023 |
| Net increase in net assets from operations | $519,811; $0.08 per share | $2.36 million; $0.38 per share in Q1 2023 |
| Net asset value (NAV) | $84.52 million; $13.60 per share | $85.55 million; $13.77 per share at December 31, 2023 |
| Portfolio investments at fair value | $54.85 million across five companies | $54.12 million across five companies at December 31, 2023 |
| Cash and cash equivalents | $33.16 million | $32.61 million at December 31, 2023 |
| Debt | None | None |
Cash provided by operating activities was $2.10 million; cash used in financing activities was $1.55 million, primarily distributions. Cash increased by $548,659 during the quarter. The filing does not provide a conventional operating margin measure.
Material changes versus comparable periods
- Investment income increased about $0.30 million year over year, primarily because of higher interest rates; it included $2.73 million of interest income and $33,750 of fee income.
- Expenses rose $1.75 million, or 161%, mainly due to $2.11 million of acquisition-related transaction expenses. Excluding that item, the expense profile would be materially different; reported net investment income moved from profit to a small loss.
- Unrealized investment appreciation was $599,620, versus $986,357 in Q1 2023. There were no realized investment gains or losses, and no purchases; principal repayments and sales were $63,000.
- The company declared and paid a $0.25-per-share distribution, totaling approximately $1.55 million. NAV per share declined from $13.77 at year-end to $13.60 at quarter-end.
Outlook, transactions, and risks
- Proposed portfolio acquisition: Under a February 18, 2024 agreement, the company proposed to acquire CALP’s loan portfolio in exchange for newly issued shares priced using values determined near closing. The portfolio comprised 24 loans valued at approximately $130 million as of January 1; CALP agreed to use reasonable best efforts to add four loans worth approximately $43 million. Closing was expected in mid-2024, subject to conditions including stockholder approval and valuation finalization. The agreement includes a potential $6.05 million termination fee in specified circumstances. Completion and final portfolio size were not assured.
- Adviser joint venture and name change: SSC announced a proposed joint venture with Chicago Atlantic. The transaction would trigger termination of the existing advisory agreement; a replacement agreement, subject to stockholder approval, was described as materially identical. The anticipated company name change was conditional on the relevant steps taking effect.
- Concentration and valuation: The portfolio was entirely classified as wholesale trade and invested in cannabis-related borrowers. Two borrowers accounted for 77.1% of portfolio fair value; the largest was 38.7%. All investment fair values were Level 3, based on significant unobservable inputs, so valuations may differ materially from amounts ultimately realized. No loans were on non-accrual, and all investments were rated risk grade 2.
- Interest-rate exposure: Approximately 84% of debt investments were floating-rate. The filing’s annualized sensitivity estimate shows net income changing by about $463,000 for a 100-basis-point rate move near the current base-rate level, with floors affecting the downside sensitivity. The company had no borrowings at quarter-end.
- Distribution and regulatory risks: The $0.25-per-share cash dividend approved May 8 was payable June 28, 2024 to holders of record June 20. Future distributions are discretionary and depend on earnings, liquidity, BDC requirements, and maintaining RIC tax status; distributions may exceed earnings or include return of capital. The filing reported no material legal proceedings, no identified commitments or contingencies, and no material risk-factor changes from the 2023 Form 10-K.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting during the quarter. Forward-looking statements remain subject to business, credit, cannabis regulation, market, interest-rate, liquidity, and valuation risks.
Important facts for investors to verify
- Confirm the issuer’s legal name and ticker for the filing period: the document identifies Silver Spike Investment Corp. (SSIC), while the requested company name is Chicago Atlantic BDC, Inc.
- Check subsequent filings for whether the CALP acquisition closed, the final assets and share issuance, stockholder approvals, and any resulting dilution or transaction costs.
- Assess the quality and downside sensitivity of the five concentrated, Level 3 borrower valuations, including the largest exposures and collateral recovery assumptions.
- Track recurring earnings after acquisition-related expenses: Q1 net investment income was negative despite higher investment income, and the $0.25 distribution exceeded quarter net investment income per share.
- Verify the effect of the adviser joint venture, replacement advisory agreement, and expanded investment mandate on governance, fees, strategy, and risk concentration.